Condition
Overdose Accidental
Total Trials
4
Recruiting
2
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 37/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 2 (1)
Trial Status
Completed2
Recruiting2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06633900Phase 2RecruitingPrimary
Naltrexone for Overdose Prevention
NCT07072819Not ApplicableCompleted
Pilot of Training on 988 and Narcan
NCT06854757Not ApplicableRecruiting
Families Left Behind
NCT06076564Completed
Leveraging Psychological Autopsies to Accelerate Research Into Stimulant Overdose Mortality
Showing all 4 trials